18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose

Trade name: FDG

Small moleculeexperimentalImaging agent

Clinical trial activity

14 trials · 28 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
5
Phase 3
2
Phase 4
0

Earliest trial started Jan 31, 2007 (NCT00634777)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetRadiopharmaceutical

    radiopharmaceutical

Chemistry & pharmacology

Imaging
18-fluorine

Oral

No

Parenteral

No

Topical

No

Also known as

  • 18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07284576Phase 2Dec 31, 2025
NCT07012993Phase 2May 20, 2025
NCT05543590N/AFeb 28, 2023Hôpital Européen Marseille
NCT05390021N/AOct 31, 2022Harvard University
NCT04831619Phase 3Jun 1, 2021Centre Hospitalier Universitaire de la Réunion
NCT04615156Phase 3Nov 1, 2020Eastern Health, Canada
NCT03295695Early Phase 1 (Phase 1)Oct 31, 2018University of South Florida
NCT03279393Early Phase 1 (Phase 1)Nov 28, 2017Harvard University, Icahn School of Medicine at Mount Sinai, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)
NCT03307941Phase 1/Phase 2 (Phase 2)Jul 20, 2017Free University of Brussels, Innate Pharma
NCT01320852N/ADec 31, 2010McGill University, Pfizer
NCT00959166N/AJun 30, 2009Imperial College London
NCT00850473N/AOct 1, 2007Washington University in St. Louis
NCT00887718N/AAug 1, 2007University of Toronto
NCT00634777N/AJan 31, 2007Cliniques universitaires Saint-Luc, Free University of Brussels, Institut Gustave Roussy, Rouen Normandy University, Université catholique de Louvain, University of Liege, University of Lille, University of Lorraine, University of Montpellier, University of Nantes, University of Paris, University of Poitiers, University of Rennes, University of Toulouse
Showing 14 of 14 trials
Page 1 / 1

Organizations

Research & Development (28)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Free University of BrusselsAcademic/Hospital2122007
Harvard UniversityAcademic/Hospital2122017
Centre Hospitalier Universitaire de la RéunionAcademic/Hospital1112021
Cliniques universitaires Saint-LucAcademic/Hospital1012007
Eastern Health, CanadaAcademic/Hospital1112020
Hôpital Européen MarseilleAcademic/Hospital1112023
Icahn School of Medicine at Mount SinaiAcademic/Hospital1112017
Imperial College LondonAcademic/Hospital1112009
Innate PharmaFor profit1012017
Institut Gustave RoussyAcademic/Hospital1012007
McGill UniversityAcademic/Hospital1112010
National Heart, Lung, and Blood Institute (NHLBI)Government1012017
National Institutes of Health (NIH)Government1012017
PfizerFor profit1012010
Rouen Normandy UniversityAcademic/Hospital1012007
Université catholique de LouvainAcademic/Hospital1112007
University of LiegeAcademic/Hospital1012007
University of LilleAcademic/Hospital1012007
University of LorraineAcademic/Hospital1012007
University of MontpellierAcademic/Hospital1012007
28 organizations
Page 1 / 2